CK1 phosphorylates GST-OREBP-(146-167) in vitro and regulates
OREBP nuclear export in vivo. A, sequence alignment of
relevant OREBP regions from human, mouse, and zebrafish (containing residues
equivalent to Ser-155 and Ser-158 of human OREBP). Conserved residues have
been boxed. B, CKI-7 inhibits in vitro
phosphorylation of Ser-158. Nuclear extracts were obtained from HeLa cells
treated with hypotonic growth medium for 30 min. GST-OREBP-(146-167) and its
mutants were incubated with the nuclear extracts in the presence of
[γ-32P]ATP and CKI-7 or ethanol (solvent) for 20 min at 30
°C. The proteins were separated by electrophoresis, stained with Coomassie
Blue (lower panel), and submitted to autoradiography (upper
panel). C, recombinant CK1α phosphorylates the
GST-OREBP-(146-167) mutant containing a phosphomimetic mutation at Ser-155
(S155D). CK1α1 (40 ng) was incubated with GST-OREBP-(146-167) or its
mutants in the presence of [γ-32P]ATP for 20 min at 30
°C. The proteins were separated by electrophoresis, stained with Coomassie
Blue (lower panel), and submitted to autoradiography (upper
panel). D, left, CKI-7 inhibits nuclear export of OREBP in
vivo. HeLa cells transfected with FLAG-OREBP-(1-581)-Δ1-131 were
pretreated with CKI-7 (100 or 200 μm) or ethanol (-) for 4 h in
growth medium (Isotonic). The cells were moved to hypotonic medium
supplemented with the same amount of the inhibitor or solvent for another 90
min (Hypotonic). FLAG-tagged recombinant protein was visualized after
fixation with a FLAG antibody and a FITC-labeled secondary antibody;
right, quantification of the subcellular localization of OREBP in the
presence of CKI-7. For each condition >100 cells were counted. The data
shown are the average of three independent experiments. E, real time
quantitative PCR of different CK1 isoforms after siRNA knockdown. HeLa cells
were transfected with the indicated siRNAs, respectively. After 72 h, mRNA was
harvested from the cells and reverse-transcribed and quantified by primers
specific to the isoform. Data were expressed as percentage relative to cells
that were not transfected(Untreated control). Cells transfected with
scramble siRNA (Nontargeting control) were also included to
demonstrate the specificity of siRNA knockdown. F, left, effect of
CK1 knockdown on nuclear export of OREBP. HeLa cells transfected with
FLAG-OREBP-(1-581)-Δ1-131 and the indicated siRNA were treated with
hypotonic medium for 90 min. FLAG-tagged recombinant protein was visualized
after fixation with a FLAG antibody and a FITC-labeled secondary antibody and
counterstained with DAPI; right, quantification of the subcellular
localization of OREBP. For each condition >100 cells were counted. The data
represented are the average of three independent experiments.